Research progress on the mechanism of transient ST elevation myocardial infarction and the best time to intervene
-
摘要: 短暂性ST段抬高型心肌梗死(transient ST elevation myocardial infarction，TSTEMI)。这类心肌梗死发作早期的表现与ST段抬高型心肌梗死类似，都有胸痛和ST段的抬高，但不同的是，TSTEMI在一段时间后ST段会出现回落，胸痛症状也会有所缓解。目前对于TSTEMI的研究较少，发生机制以及最佳介入时机也存在争议。本文对TSTEMI的发生机制以及最佳介入时机进行综述，以期为TSTEMI患者的临床管理提供参考。
-
关键词:
- 心肌梗死 /
- ST段抬高型心肌梗死, 短暂性 /
- 机制 /
- 介入治疗时机
Abstract: A special type of myocardial infarction has been identified-transient ST elevation myocardial infarction(TSTEMI). The early symptoms of this type of heart attack are similar to STEMI, with chest pain and elevation of the ST segment, but the difference is that TSTEMI will drop back after a period of time, and the chest pain symptoms will be relieved. At present, there are few studies on TSTEMI, and the mechanism of TSTEMI and the best time to intervene are also controversial. This article reviews the mechanism of TSTEMI and the best time to intervene, in order to provide reference for the clinical management of TSTEMI patients. -
-
[1] Nguyen TM, Melichova D, Aabel EW, et al. Mortality in patients with acute coronary syndrome-a prospective 5-year follow-up study[J]. J Clin Med, 2023, 12(20): 110.
[2] Jenča D, Melenovsky V, Stehlik J, et al. Heart failure after myocardial infarction: incidence and predictors[J]. ESC Heart Fail, 2021, 8(1): 222-237. doi: 10.1002/ehf2.13144
[3] 杨月霞, 刘中慧, 王怀新. 尼可地尔对急性ST段抬高型心肌梗死患者Tp-Te间期和Tp-Te/QT以及预后的影响[J]. 临床急诊杂志, 2023, 24(11): 567-572, 577. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202311003.htm
[4] Janssens GN, Lemkes JS, van der Hoeven NW, et al. Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome[J]. Int J Cardiol, 2021, 336: 22-28. doi: 10.1016/j.ijcard.2021.05.018
[5] Ong L, Reiser P, Coromilas J, et al. Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion[J]. N Engl J Med, 1983, 309(1): 1-6. doi: 10.1056/NEJM198307073090101
[6] Meisel SR, Dagan Y, Blondheim DS, et al. Transient ST-elevation myocardial infarction: clinical course with intense medical therapy and early invasive approach, and comparison with persistent ST-elevation myocardial infarction[J]. Am Heart J, 2008, 155(5): 848-854. doi: 10.1016/j.ahj.2007.12.010
[7] Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology(ESC)[J]. Euro Heart J, 2016, 37(3): 267-315. doi: 10.1093/eurheartj/ehv320
[8] Farag M, Peverelli M, Spinthakis N, et al. Spontaneous reperfusion in patients with transient ST-elevation myocardial infarction-prevalence, importance and approaches to management[J]. Cardiovasc Drugs Ther, 2023, 37(1): 169-180. doi: 10.1007/s10557-021-07226-7
[9] Meisel SR, Kleiner-Shochat M, Fanne RA, et al. Optimal timing for coronary intervention in patients with transient ST-elevation myocardial infarction[J]. Am J Cardiol, 2019, 124(12): 1821-1826. doi: 10.1016/j.amjcard.2019.09.005
[10] 肖立运, 李秀丽, 许胜. 肝素早期预处理对急诊介入治疗STEMI患者梗死相关血管血流及对炎性因子和远期心功能影响[J]. 临床急诊杂志, 2023, 24(10): 516-522. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202310005.htm
[11] Shi X, Yang J, Huang J, et al. Effects of different shear rates on the attachment and detachment of platelet thrombi[J]. Mol Med Rep, 2016, 13(3): 2447-2456. doi: 10.3892/mmr.2016.4825
[12] Gorog DA. Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications[J]. J Thromb Thrombolysis, 2018, 45(4): 593-602. doi: 10.1007/s11239-018-1641-2
[13] Guo J, Chen J, Wang G, et al. Plaque characteristics in patients with ST-segment elevation myocardial infarction and early spontaneous reperfusion[J]. EuroIntervention, 2021, 17(8): e664-e671. doi: 10.4244/EIJ-D-20-00812
[14] Chen J, Wang G Z, Liu Z, et al. 99Non-ruptured plaque and platelet-rich thrombi in ST-segment elevation myocardial infarction: new insight into early spontaneous reperfusion[J]. Eur Heart J, 2019, Supplement: 1.
[15] Kanji R, Gue YX, Memtsas V, et al. Biomarkers of thrombotic status predict spontaneous reperfusion in patients with ST-segment elevation myocardial infarction[J]. J Am Coll Cardiol, 2023, 81(19): 1918-1932. doi: 10.1016/j.jacc.2023.03.388
[16] Byrne RA, Colleran R. Shedding light on the optimal management of patients presenting with transient ST-segment elevation[J]. JACC Cardiovasc Interv, 2019, 12(22): 2283-2285. doi: 10.1016/j.jcin.2019.08.022
[17] Ownbey M, Suffoletto B, Frisch A, et al. Prevalence and interventional outcomes of patients with resolution of ST-segment elevation between prehospital and in-hospital ECG[J]. Prehosp Emerg Care, 2014, 18(2): 174-179. doi: 10.3109/10903127.2013.851310
[18] Wang J, He SY. Clinical and angiographic characteristics of patients with spontaneous reperfusion in ST-segment elevation myocardial infarction[J]. Medicine(Baltimore), 2020, 99(10): e19267.
[19] Blondheim DS, Kleiner-Shochat M, Asif A, et al. Characteristics, management, and outcome of transient ST-elevation versus persistent ST-elevation and Non-ST-elevation myocardial infarction[J]. Am J Cardiol, 2018, 121(12): 1449-1455. doi: 10.1016/j.amjcard.2018.02.029
[20] Yonetsu T, Lee T, Murai T, et al. Association between prior aspirin use and morphological features of culprit lesions at first presentation of acute coronary syndrome assessed by optical coherence tomography[J]. Circ J, 2017, 81(4): 511-519. doi: 10.1253/circj.CJ-16-0957
[21] Hashimoto T, Ako J, Nakao K, et al. Pre-procedural thrombolysis in myocardial infarction flow in patients with ST-segment elevation myocardial infarction[J]. Int Heart J, 2018, 59(5): 920-925. doi: 10.1536/ihj.17-518
[22] Bailleul C, Puymirat E, Aissaoui N, et al. Factors associated with infarct-related artery patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction(from the FAST-MI 2010 Registry)[J]. Am J Cardiol, 2016, 117(1): 17-21. doi: 10.1016/j.amjcard.2015.09.043
[23] 王功旭, 朱诗苗. 急诊PCI术后发生无复流与术前患者PLA值和肾功能变化的关系[J]. 临床急诊杂志, 2023, 24(4): 207-211. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202304007.htm
[24] Spinthakis N, Gue Y, Farag M, et al. Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation[J]. Europace, 2019, 21(9): 1297-1306. doi: 10.1093/europace/euz176
[25] Berg DD, Moura FA, Bellavia A, et al. Assessment of atherothrombotic risk in patients with type 2 diabetes mellitus[J]. J Am Coll Cardiol, 2023, 81(25): 2391-2402. doi: 10.1016/j.jacc.2023.04.031
[26] Lu X, Zhang L, Li S, et al. Association between statin use and the prognosis of patients with acute myocardial infarction complicated with diabetes[J]. Front Cardiovasc Med, 2022, 9: 976656. doi: 10.3389/fcvm.2022.976656
[27] Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes[J]. Eur Heart J, 2023, 44(38): 3720-3826. doi: 10.1093/eurheartj/ehad191
[28] Koc L, Mikolaskova M, Novotny T, et al. Primary percutaneous coronary intervention is appropriate in transient ST-elevation myocardial infarction[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2022, 166(2): 180-186. doi: 10.5507/bp.2021.005
[29] Badings EA, Remkes WS, The SH, et al. Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial[J]. Catheter Cardiovasc Interv, 2016, 88(5): 755-764. doi: 10.1002/ccd.26719
[30] Lemkes JS, Janssens GN, van der Hoeven NW, et al. Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial[J]. Eur Heart J, 2019, 40(3): 283-291. doi: 10.1093/eurheartj/ehy651
[31] Camaro C, Damman P. Antithrombotic PreTreatment and Invasive Strategies in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome[J]. J Clin Med, 2020, 9(8): 110.
[32] Butt JH, Kofoed KF, Kelbæk H, et al. Importance of risk assessment in timing of invasive coronary evaluation and treatment of patients with non-ST-segment-elevation acute coronary syndrome: Insights From the VERDICT Trial[J]. J Am Heart Assoc, 2021, 10(19): e022333. doi: 10.1161/JAHA.121.022333
[33] Arroyo Ucar E, Domínguez-Rodríguez A, Juárez Prera R, et al. Differential characteristics of patients with acute coronary syndrome without ST-segment elevation compared to those with transient ST-segment elevation[J]. Med Intensiva, 2011, 35(5): 270-273. doi: 10.1016/j.medin.2011.01.007
[34] Kofoed KF, Kelbæk H, Hansen PR, et al. Early versus standard care invasive examination and treatment of patients with non-ST-segment elevation acute coronary syndrome[J]. Circulation, 2018, 138(24): 2741-2750. doi: 10.1161/CIRCULATIONAHA.118.037152
[35] Demirkiran A, van der Hoeven NW, Janssens GN, et al. Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions[J]. Eur Heart J Cardiovasc Imaging, 2022, 23(6): 836-845. doi: 10.1093/ehjci/jeab114
[36] Fefer P, Beigel R, Atar S, et al. Outcomes of patients presenting with clinical indices of spontaneous reperfusion in ST-elevation acute coronary syndrome undergoing deferred angiography[J]. J Am Heart Assoc, 2017, 6(7): 110.
[37] Janssens GN, van der Hoeven NW, Lemkes JS, et al. 1-Year outcomes of delayed versus immediate intervention in patients with transient ST-segment elevation myocardial infarction[J]. JACC Cardiovasc Interv, 2019, 12(22): 2272-2282. doi: 10.1016/j.jcin.2019.07.018
-
计量
- 文章访问数: 371
- 施引文献: 0
下载: